Clinical Trial Search

Primary: Evidence of Carotid Artery or Intracranial Artery Atherosclerosis Confirmed by Vascular Ultrasonography — 96; 1063; 826; 241 artery numbers

Primary: Academic Performance: Grade Point Averages — 85.71; 83.45 per cent — p=0.54

Primary: Percentage of Participants With Successful Eradication of H. Pylori — 91.4; 81.5 percentage of eradication

Primary: Cure Rate for Ascaris Lumbricoides at the End of Double-blind Treatment Period — 11.1; 83.7 percentage of participants — p=< 0.001

Primary: Change From Baseline in the Physical Component Scale (PCS) of the Short Form 36 Health Status Questionnaire (SF-36) At Months 3, 6, 9, and 12: Responders — 4.2; 3.4…

Primary: Biochemical Disease Free Survival: Estimated Percentage of Participants With Biochemical Disease-free Survival at 5 Years — 90; 81 percentage of patients — p=0.01

Primary: Syncope Recurrence Rate

Primary: Cigarettes Per Smoking Day — 4.9256; 8.4989 Cigarettes per smoking day

Primary: Extension Deficit in the Affected Distal Interphalangeal Joint. — 12; 10 degrees extension deficit

Primary: Geometric Mean Titers of Influenza Antibodies Before and After Vaccination With a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route — 142; 116…

Primary: Objective Response Rate (CR + PR) — 46.7 percentage of participants

Primary: Number of Doses of Fentanyl Administered in the Postoperative Period Prior to Discharge. — 1.5; 1.7 fentanyl doses

Primary: Percentage of Participants With Serum Urate <5.0 mg/dL at Month 3 — 0; 13.5; 35.9; 40.5 percentage of participants — p=<0.001

Primary: Percentage of Participants Achieving the Combined Response at the End of the Follow-up Period — 11.8; 25.0; 20.0 percentage of participants — p=0.08

Primary: Number of Participants That Performed Regular Self-Skin Examinations — 8; 16; 23; 25 participants — p=0.048